Breast Cancer Res Treat (2017) 165:445–453 DOI 10.1007/s10549-017-4345-y EPIDEMIOLOGY Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis 1 1 1 1 • • • • Tejan P. Diwanji Jason K. Molitoris Arpit M. Chhabra James W. Snider 2 3 3 • • • Soren M. Bentzen Katherine H. Tkaczuk Paula Y. Rosenblatt 4 4 5 5 • • • • Susan B. Kesmodel Emily C. Bellavance Randi J. Cohen Sally B. Cheston 5 5 Elizabeth M. Nichols Steven J. Feigenberg Received: 24 May 2017 / Accepted: 16 June 2017 / Published online: 21 June 2017 Springer Science+Business Media, LLC 2017 Abstract Results A total of 56,836 women were treated with Purpose Results from four major hypofractionated whole- chemotherapy and WBRT (without regional nodal irradia- breast radiotherapy (HF-WBRT) trials have demonstrated tion) from 2004 to 2013; 9.0% (n = 5093) were treated with equivalence in select patients with early-stage breast cancer HF-WBRT. Utilization of HF-WBRT increased from 4.6% in when compared with conventionally fractionated WBRT 2004 to 18.2% in 2013 (odds ratio [OR] 1.21/year; (CF-WBRT). Because relatively little data were available P\ 0.001). Among patients receiving chemotherapy, factors on patients receiving neoadjuvant or
Breast Cancer Research and Treatment – Springer Journals
Published: Jun 21, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera